FDA Approved: SILODOSIN — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved Ajanta Pharma USA Inc.'s supplemental application for silodosin, enabling regulatory clearance related to the generic product under ANDA 211060…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)